Accession Number: | 0001140361-21-020429 |
Date: | 2021-06-08 |
Issuer: | ATARA BIOTHERAPEUTICS, INC. (ATRA) |
Original Submission Date: |
BAYNES ROY D.
611 GATEWAY BOULEVARD
SUITE 900
SOUTH SAN FRANCISCO, CA 94080
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-06-08 | A | 11,000 | a | $0.00 | 23,000 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
NON-QUALIFIED STOCK OPTION (RIGHT TO BUY) | 13.8 | 2021-06-08 | deemed execution date | A | 17,500 (a) | 2031-06-07 | common stock 17,500 | $13.80 | 17,500 | direct |
ID | footnote |
---|---|
f1 | these restricted stock units shall vest on the earlier of june 8, 2022 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service. |
f2 | the option shall vest on the earlier of june 8, 2022 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service. |